PTX-25F

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePTX-25F
Drug Alias NameTL1A-Ig fusion protein (Pelican Therapeutics)PTX-25F
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor superfamily member 15 modulatorsImmunoglobulin G agonists
TargetsImmunoglobulin GTumor necrosis factor superfamily member 15
Therapy Area/IndicationsAutoimmune Diseases +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPelican Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPelican Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases +[2] 

Other Information

ATC CodeN/A
Related LinksN/A